Crossmark

Elimination of onchocerciasis in Ecuador: findings of post-treatment surveillance

Crossref DOI link: https://doi.org/10.1186/s13071-018-2851-3

Published Online: 2018-04-24

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Guevara, Ángel

Lovato, Raquel

Proaño, Roberto

Rodriguez-Perez, Mario A.

Unnasch, Thomas

Cooper, Philip J.

Guderian, Ronald H.
Funding

Funding for this research was provided by:

Onchocerciasis Elimination Program for the Americas

Ministerio de Salud del Ecuador

Hospital Vozandes de Quito

Chistoffel Blindenmission-Ecuador

The Mectizan Donation Program
License Information

Text and Data Mining valid from 2018-04-24
More Information

Article History

Received: 11 December 2017

Accepted: 16 April 2018

First Online: 24 April 2018

Ethics approval and consent to participate

: The distribution of drugs, the collection of skin and blood samples as part of the national elimination programme, as well as the collection of vectors, was approved and monitored by the National Ministry of Health as being ethical, safe, and of benefit to the local people. All the activities of the National Elimination Programme for Onchocerciasis complied with current national and international regulations and standards for biomedical research in human subjects.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.